levetiracetam
levetiracetam: sourced relationships with 1 company · 5 clinical trials tracked · 1 FDA decision.
levetiracetam evidence translation
What we can confirm
1 FDA record · 5 tracked trials
What it means
What to watch
Prepared research question
How could levetiracetam → NEXS affect its developer, and what evidence supports the link?
Traceable citations · Unknowns marked
See linked entities and source evidence3 indications · 0 study sponsors
Related indications
Study sponsors
No additional listed-company sponsor is linked.
Dated Pipeline Records (2)
| Company | Dated record stage |
|---|---|
| NEXUS BIOPHARMA INC (NEXS) Reported 2020-07-06 · Current development: unknownSource | Approved |
| NEXUS BIOPHARMA INC (NEXS) Reported 2020-07-06 · Current development: unknownSource | Approved |
Clinical Trial Registry Records (5)
Ketamine add-on Therapy for Established Status Epilepticus Treatment Trial (KESETT)
Primary endpoint: Termination of SE
High Dose Ruxolitinib and Allogeneic Stem Cell Transplantation in Myelofibrosis Patients With Splenomegaly
Primary endpoint: Safety and adverse events (AEs)
Pharmacokinetics and Safety of Commonly Used Drugs in Lactating Women and Breastfed Infants
Primary endpoint: M/P ratio
Reducing Hippocampal Hyperactivity and Improving Cognition in Schizophrenia
Primary endpoint: Neurocognitive Function
Neuroblastoma Protocol 2012: Therapy for Children With Advanced Stage High-Risk Neuroblastoma
Primary endpoint: Overall Response Rate [Complete Response + Very Good Partial Response + Partial Response (CR + VGPR + PR)]
Frequently asked questions
Which companies have sourced relationships with levetiracetam?
levetiracetam has dated SEC/FDA relationship records for NEXUS BIOPHARMA INC.
How many clinical trials involve levetiracetam?
BioSniper tracks 5 clinical trials involving levetiracetam.
What is levetiracetam's latest FDA decision?
The most recent tracked FDA decision for levetiracetam is Approval, dated July 6, 2020.